To speed claims processing, payers should allow a non-NPI prescriber ID

Article

The Centers for Medicare & Medicaid Services has issued an FAQ that explains about the use of a non-NPI for prescribers who are not covered entities.

Payers can work with pharmacies to come up with a non-national provider identifier or default alternative on billing transactions for physicians who do not use an NPI. In an FAQ #9100, the Centers for Medicare & Medicaid Services explained that some physicians are not covered entities and do not require an NPI. In such cases, a pharmacy can use a non-NPI prescriber ID if allowed by the payer. However, CMS cautioned that this default should be used only in rare cases.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, click here.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!
Recent Videos
Related Content
Iowa Governor Signs Bill Limiting PBM Practices

Iowa Governor Signs Bill Limiting PBM Practices

Brian Nowosielski
June 12th 2025
Article

SF 383 prohibits PBMs from limiting patient choice of pharmacy, unfairly excluding pharmacies from networks, and forces them to reimburse pharmacies no less than what they pay affiliated pharmacies for the same drug.

Pharmacy Law Lowdown: PBM Audit Trends, Enforcement Actions

Pharmacy Law Lowdown: PBM Audit Trends, Enforcement Actions

Killian Meara;Dae Lee, PharmD, Esq, CPBS ;Lucas Morgan, Esq
May 14th 2025
Podcast

Dae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.

Q&A: Workflow Changes Needed as Pharmacies Take on Clinical Roles | PQA 2025

Q&A: Workflow Changes Needed as Pharmacies Take on Clinical Roles | PQA 2025

Killian Meara;Michael Hegener, PharmD, BCACP
May 27th 2025
Article

Michael Hegener, PharmD, BCACP, discusses what workflow changes are essential to support the expansion of patient care services in community pharmacies.

The Current, Future Roles of AI within the Pharmacy Profession

The Current, Future Roles of AI within the Pharmacy Profession

Brian Nowosielski;Scott Nelson, PharmD, MS, FAMIA, ACHIP
February 27th 2025
Podcast

As artificial intelligence evolves from a novel technology to commonplace in health care, the pharmacy industry is adapting to its challenges and opportunities.

How PBMs Impede Pharmacists’ Ability to Perform Clinical Services | APhA 2025

How PBMs Impede Pharmacists’ Ability to Perform Clinical Services | APhA 2025

Brian Nowosielski
March 31st 2025
Article

Antonio Ciaccia, President of 3 Axis Advisors, led a discussion on pharmacy benefit manager reform and how the inability to pass legislation has led to increased financial hardships in community pharmacy.

FDA Approves Fitusiran as Prophylaxis of Bleeding Episodes Due to Hemophilia A or B

FDA Approves Fitusiran as Prophylaxis of Bleeding Episodes Due to Hemophilia A or B

Ashley Gallagher
March 28th 2025
Article

Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.

© 2025 MJH Life Sciences

All rights reserved.